Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.

Munoz DG, Fujioka S.

Neurology. 2018 Jan 30;90(5):205-206. doi: 10.1212/WNL.0000000000004898. Epub 2018 Jan 3. No abstract available.

PMID:
29298853
2.

Relationship between caffeine intake and Parkinson disease.

Honig LS.

JAMA. 2000 Sep 20;284(11):1378-9. No abstract available.

PMID:
10989385
3.

Caffeine and progression of Parkinson disease.

Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC; NET-D Investigators.

Clin Neuropharmacol. 2008 Jul-Aug;31(4):189-96. doi: 10.1097/WNF.0b013e31815a3f03.

4.

Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.

Deleu D, Jacob P, Chand P, Sarre S, Colwell A.

Neurology. 2006 Sep 12;67(5):897-9.

PMID:
16966563
5.

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS.

Clin Neuropharmacol. 2015 Sep-Oct;38(5):163-9. doi: 10.1097/WNF.0000000000000102.

6.

Caffeine in Parkinson disease: better for cruise control than snooze patrol?

Schwarzschild MA.

Neurology. 2012 Aug 14;79(7):616-8. doi: 10.1212/WNL.0b013e318263580e. Epub 2012 Aug 1. No abstract available.

PMID:
22855870
7.

Comment: Caffeine and PD-Time to consider other interventions.

Hall CB.

Neurology. 2017 Oct 24;89(17):1802. doi: 10.1212/WNL.0000000000004584. Epub 2017 Sep 27. No abstract available.

PMID:
28954875
8.

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.

Ohmichi T, Kasai T, Kosaka T, Shikata K, Tatebe H, Ishii R, Shinomoto M, Mizuno T, Tokuda T.

PLoS One. 2018 Jul 25;13(7):e0201260. doi: 10.1371/journal.pone.0201260. eCollection 2018.

9.

Can dietary substances protect against Parkinson's disease? The case of caffeine.

Morelli M, Simola N.

Exp Neurol. 2010 Oct;225(2):246-9. doi: 10.1016/j.expneurol.2010.07.017. Epub 2010 Jul 24. No abstract available.

PMID:
20659450
10.

Caffeine intake, smoking, and risk of Parkinson disease in men and women.

Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, Hollenbeck AR, Blair A, Chen H.

Am J Epidemiol. 2012 Jun 1;175(11):1200-7. doi: 10.1093/aje/kwr451. Epub 2012 Apr 13.

11.

[Connection between caffeine, adenosine receptors and dopamine. Coffee reduces the risk of Parkinson disease].

Fredholm BB.

Lakartidningen. 2004 Aug 19;101(34):2552-5. Review. Swedish. No abstract available.

PMID:
15446691
12.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

13.

Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B.

Neurology. 2012 Aug 14;79(7):651-8. doi: 10.1212/WNL.0b013e318263570d. Epub 2012 Aug 1. Erratum in: Neurology. 2012 Oct 16;79(16):1744.

14.

Association of coffee and caffeine intake with the risk of Parkinson disease.

Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR.

JAMA. 2000 May 24-31;283(20):2674-9.

PMID:
10819950
15.

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.

Hancock DB, Martin ER, Stajich JM, Jewett R, Stacy MA, Scott BL, Vance JM, Scott WK.

Arch Neurol. 2007 Apr;64(4):576-80.

PMID:
17420321
16.

Caffeine in Parkinson's disease: comment on its importance and the dose proposal.

Kitagawa M, Houzen H, Tashiro K.

Mov Disord. 2012 May;27(6):808. doi: 10.1002/mds.24988. Epub 2012 Apr 12. No abstract available.

PMID:
22499388
17.

Caffeine; the Forgotten Potential for Parkinson's Disease.

Negida A, Elfil M, Attia, Farahat E, Gabr M, Essam A, Attia D, Ahmed H.

CNS Neurol Disord Drug Targets. 2017;16(6):652-657. doi: 10.2174/1871527315666161107091149. Review.

PMID:
27823571
18.

Effects of caffeine on the freezing of gait in Parkinson's disease.

Kitagawa M, Houzen H, Tashiro K.

Mov Disord. 2007 Apr 15;22(5):710-2.

PMID:
17373724
19.

Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.

Kenborg L, Lassen CF, Ritz B, Andersen KK, Christensen J, Schernhammer ES, Hansen J, Wermuth L, Rod NH, Olsen JH.

Am J Epidemiol. 2015 May 15;181(10):808-16. doi: 10.1093/aje/kwu332. Epub 2015 Apr 29.

20.

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

Ascherio A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, Willett WC.

Ann Neurol. 2001 Jul;50(1):56-63.

PMID:
11456310

Supplemental Content

Support Center